2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Pupil Disorders: new trials by email Literature Review of Pupil Disorders trials Research Report on Pupil Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution IMP 08P2002F0, Mydriasert® insert - Mydriasis | Phase 1 / Phase 2 | Completed | Unither Pharmaceuticals, France | 20 | 2025-11-01 | 2026-06-17 |
| The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients Alphagan, Phenylephrine, Tropicamide - Intraocular Pressure | Phase 1 | Completed | Wake Forest University Health Sciences | 5 | 2016-09-01 | 2018-08-09 |
Mydriasis (2)
Eye Diseases (2)
Brimonidine Tartrate (1) · Phenylephrine (1) · Tropicamide (1)
Unither Pharmaceuticals, France (1) · Wake Forest University Health Sciences (1)
Greece (1) · United States (1)
Keith Walter, MD (1)